You are viewing: Japan Diagnostic Imaging Market analysis
Part of: Diagnostic Imaging Market (Global)

The Japan Diagnostic Imaging Market was valued at $2155.4 Million in 2025 and projected to reach to $3045.6 Million by 2030, representing a compound annual growth rate of 7.2%. Japan's diagnostic imaging market is positioned for sustained growth through 2030, driven by the convergence of demographic shifts, technological innovation, and healthcare policy support.

Japan Diagnostic Imaging Market Trends and Insights

  • Japan's aging population and rising prevalence of chronic diseases are driving demand for advanced imaging technologies including MRI, CT, and ultrasound systems.
  • Japan's healthcare infrastructure investments and emphasis on early disease detection position the country as a key growth market in the Asia Pacific region. The diagnostic imaging sector in Japan is characterized by high adoption of cutting-edge medical technologies and strong government support for healthcare modernization.
  • Japan's market growth rate of 7.2% CAGR significantly outpaces the global average, reflecting the country's commitment to improving diagnostic capabilities and patient outcomes.
  • Between 2025 and 2030, Japan is expected to see increased deployment of AI-integrated imaging systems and portable diagnostic devices across hospitals and diagnostic centers..

Key Market Statistics

  • CAGR (2025-2030) 7.2% CAGR
  • Market Size, 2025 ~USD 2155.4 Million
  • Forecast, 2030 ~USD 3045.6 Million
  • Country Japan

Japan Diagnostic Imaging Market Overview

Aging Population Driving Demand :

Japan's rapidly aging demographic, with over 29% of the population aged 65+, is significantly increasing the demand for diagnostic imaging services for age-related conditions including cancer, cardiovascular disease, and neurological disorders.

Advanced Technology Adoption :

Japanese healthcare providers are investing heavily in cutting-edge imaging technologies such as 3D ultrasound, hybrid PET-CT systems, and AI-integrated diagnostic platforms to enhance diagnostic accuracy and patient outcomes.

Government Healthcare Initiatives :

Japan's government-backed healthcare modernization programs and emphasis on early disease detection through comprehensive screening programs are accelerating the adoption of diagnostic imaging across hospitals and clinics nationwide.

Strong Market Growth Trajectory :

With a CAGR of 7.2% from 2025 to 2030, Japan's diagnostic imaging market is expanding faster than the global average of 4.4%, reflecting the country's commitment to healthcare excellence and technological advancement.

Japan Diagnostic Imaging Market Dynamics

  • The nation's aging population creates persistent demand for advanced imaging modalities, while Japanese manufacturers' leadership in medical device innovation ensures continuous product improvements and market competitiveness.
  • Healthcare facilities are increasingly adopting integrated imaging solutions that combine multiple modalities with artificial intelligence for enhanced diagnostic precision.
  • Government reimbursement policies and universal healthcare coverage provide stable market conditions for sustained investment in imaging infrastructure across urban and regional medical centers..

Related Ecosystem

Diagnostic Imaging

Top Technologies
  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography (CT)
  • CT Scanners
  • Nuclear Imaging
  • Positron Emission Tomography
Top Companies
  • Siemens healthineers
  • PHILIPS HEALTHCARE
  • CANON INC.
  • FUJIFILM Holdings Corporation
  • UNITED IMAGING HEALTHCARE CO., LTD.

    Medical Devices

    Top Technologies
    • Polymerase Chain Reaction (PCR)
    • Magnetic Resonance Imaging (MRI)
    • Disposable Autoinjectors
    • Pulse Oximeters
    • Blood Pressure Monitors
    Top Companies
    • Medtronic plc
    • Stryker Corporation
    • Abbott Laboratories
    • Becton, Dickinson and Company
    • JOHNSON & JOHNSON

      Key Takeaways

      • Japan's diagnostic imaging market will grow from USD 2,155.4M (2025) to USD 3,045.6M (2030) at a 7.2% CAGR, outpacing global growth rates.
      • Japan's aging demographic and high prevalence of chronic diseases are primary drivers of diagnostic imaging demand.
      • Japan is rapidly adopting AI-integrated and portable imaging technologies to enhance diagnostic efficiency and accessibility.
      • Japan's strong healthcare infrastructure and government support create a favorable environment for market expansion through 2030.

      Diagnostic Imaging Market Report Scope

      Report Metric Details
      Base Year 2025
      Fastest Growing Segment ULTRA-HIGH-FIELD (Field Strength)
      Forecast Period 2025–2030
      Growth Rate CAGR of 4.4% from 2025 to 2030
      Largest Segment HOSPITALS (End User)
      Market Size Base Year (Billions) ~USD 26.53 (2025)
      Revenue Forecast (Billions) ~USD 32.9 (2030)
      Segments Covered Application, Modality, Type, Technology, Portability, Architecture, Field Strength, End User

      Japan Diagnostic Imaging Market Report Segmentation

      8 segment dimensions are covered across the global market.

      By Application

      • Brain & Neurological Mri
      • Breast Mri
      • Cardiac Mri
      • Cardiology
      • Dentistry
      • Fluoroscopy
      • General Radiography
      • Neurology
      • Obstetrics/Gynecology
      • Oncology
      • Other Applications
      • Pelvic & Abdominal Mri
      • Radiology/General Imaging
      • Spine & Musculoskeletal Mri
      • Urology
      • Vascular
      • Vascular Mri

      By Modality

      • Ct Scanners
      • Mammography Systems
      • Mri Systems
      • Nuclear Imaging Systems
      • Ultrasound
      • Ultrasound Systems
      • X-Ray Imaging Systems

      By Type

      • Analog
      • Analog X-Ray Imaging Systems
      • Cone-Beam
      • Conventional
      • Conventional Ct
      • Digital
      • Digital X-Ray Imaging Systems
      • High-Slice
      • Hybrid Spect
      • Hybrid Spect Systems
      • Low-Slice
      • Mid-Slice
      • Pet
      • Pet Systems
      • Spect
      • Spect Systems

      By Technology

      • 2D
      • 2D Ultrasound
      • 3D & 4D
      • 3D And 4D Ultrasound
      • Contrast-Enhanced
      • Contrast-Enhanced Ultrasound Systems
      • Doppler Imaging
      • Doppler Imaging Systems

      By Portability

      • Compact/Portable
      • Portable
      • Portable X-Ray
      • Stationary
      • Stationary X-Ray
      • Trolley/Cart-Based

      By Architecture

      • Closed
      • Open

      By Field Strength

      • High & Very High-Field
      • High And Very-High-Field
      • Low-To-Mid-Field
      • Ultra-High-Field

      By End User

      • Diagnostic Imaging Centers
      • Hospitals
      • Other End Users

      Target Audience

      • Medical Device Manufacturers : Manufacturers of diagnostic imaging equipment need Japan-specific market data to develop localized product strategies, understand competitive positioning, and identify growth opportunities in this technologically advanced and aging-population-driven market.
      • Healthcare Facility Operators : Hospital administrators and imaging center operators require market insights to justify capital investments in new imaging technologies, benchmark against industry standards, and plan facility expansion aligned with demographic demand trends.
      • Investment & Private Equity Firms : Investors evaluating opportunities in Japan's healthcare sector need comprehensive market data to assess growth potential, identify acquisition targets, and make informed decisions about portfolio allocation in diagnostic imaging.
      • Healthcare Consultants & Advisors : Consulting firms advising healthcare organizations and medical device companies require detailed Japan market analysis to develop strategic recommendations, competitive assessments, and market entry strategies for their clients.
      • Government & Policy Makers : Healthcare policy officials and government agencies need market intelligence to inform healthcare infrastructure planning, reimbursement policy development, and technology adoption initiatives aligned with Japan's aging population needs.

      Key Companies in the Japan Diagnostic Imaging Market

      CompanyHQOwnershipStrongest segments
      TOSHIBA CORPORATIONJapanPrivate CompanyEnergy Systems & Solutions,Infrastructure Systems & Solutions,Electronic Devices and Storage Solutions,
      AT&SCanadaPublic CompanyCustom automated manufacturing and assembly systems,Pre- and post-automation lifecycle services,Contract manufacturing and integration services,
      HEALTHFUSION INC.United StatesPrivate CompanyMediTouch EHR (clinical module),Practice Management & Scheduling,Clearinghouse & Revenue Cycle Transactions,
      UNILABSSwitzerlandPrivate CompanyCore laboratory testing,Medical imaging,Pathology and centres of excellence,
      UNITED IMAGING HEALTHCARE CO., LTD.ChinaPublic CompanyMagnetic Resonance Imaging,Computed Tomography,Molecular Imaging (PET/CT, SPECT),
      SIEMENS HEALTHINEERSGermanyPublic Company
      GE HEALTHCAREUnited StatesPublic CompanyImaging,Advanced Visualization Solutions (AVS),Patient Care Solutions (PCS),
      KONINKLIJKE PHILIPS N.V.NetherlandsPublic CompanyDiagnostic Imaging (MR, CT, X-ray, Ultrasound),Image Guided Therapy Systems and Devices,Monitoring and Enterprise Informatics,
      FUJIFILM CORPORATIONJapanPublic CompanyHealthcare (medical systems, CDMO, pharma, regenerative, cosmetics/supplements),Electronics (display, semiconductors, storage, industrial equipment, fine chemicals),Business Innovation (office equipment, document services, graphic communications, inkjet),
      CANONJapanPublic CompanyPrinting Business Unit (office, production, large-format, document solutions),Imaging Business Unit (cameras, lenses, network cameras, cinema/broadcast),Medical Business Unit (diagnostic imaging, ophthalmology, IVD, healthcare IT),
      SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.ChinaPublic CompanyPatient monitoring, anesthesia, ventilators, and defibrillation,Ultrasound and radiology imaging,In-vitro diagnostics (CLIA, chemistry, hematology),
      ESAOTE S.P.AItalyPrivate CompanyUltrasound diagnostic imaging systems,Dedicated MRI systems (MSK, weight-bearing, head),Healthcare IT software (radiology, cardiology, oncology),
      SHIMADZU CORPORATIONJapanPublic CompanyAnalytical and Measuring Instruments,Medical Systems (Imaging and Fluorescence),Industrial and Vacuum Machinery,
      HOLOGIC, INC.United StatesPrivate CompanyDiagnostics (Panther/Aptima and related assays),Breast Health (3D mammography, biopsy, imaging software, service),GYN Surgical (MyoSure, NovaSure, Acessa, Fluent, CoolSeal),
      AGFA-GEVAERT GROUPBelgiumPublic CompanyHealthcare enterprise imaging platform and software,Diagnostic imaging hardware, X-ray film, and hardcopy,Sign and display and packaging printers, inks, and software,
      CURVEBEAM AI, LTD.United StatesPublic CompanyLower extremity weight-bearing CT (LineUP, pedCAT, pedCAT Premium, TALAS, Autometrics, Axiometrics),HiRise bilateral weight-bearing CT (multi-joint, including hip and full lower limb),Upper extremity and general point-of-care CT (InReach, OSSView, CubeVue, custom cloud platforms),

      TOSHIBA CORPORATION

      Toshiba Corporation is a private company founded in 1875 and based in Japan with 106,648 employees.

      AT&S

      AT&S is a public company founded in 1978 and based in Canada with 7,000 employees.

      HEALTHFUSION INC.

      HealthFusion Inc. is a private company founded in 1998 and based in the United States with 120 employees.

      UNILABS

      Unilabs is a private company founded in 1987 and based in Switzerland with 1,897 employees.

      UNITED IMAGING HEALTHCARE CO., LTD.

      United Imaging Healthcare Co., Ltd. is a public company founded in 2011 and based in China with 8,703 employees.

      SIEMENS HEALTHINEERS

      Siemens Healthineers is a public company founded in 1896 and based in Germany with 72,369 employees.

      GE HEALTHCARE

      GE Healthcare is a public company founded in 2022 and based in the United States with 54,000 employees.

      KONINKLIJKE PHILIPS N.V.

      Koninklijke Philips N.V. is a public company founded in 1891 and based in the Netherlands with 64,317 employees.

      FUJIFILM CORPORATION

      Fujifilm Corporation is a public company founded in 1934 and based in Japan with 73,526 employees.

      CANON

      Canon is a public company founded in 1933 and based in Japan with 165,547 employees.

      SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.

      Shenzhen Mindray Bio-Medical Electronics Co., Ltd. is a public company founded in 1991 and based in China with 21,288 employees.

      ESAOTE S.P.A

      Esaote S.p.A. is a private company founded in 1982 and based in Italy with 1,067 employees.

      SHIMADZU CORPORATION

      Shimadzu Corporation is a public company founded in 1875 and based in Japan with 14,649 employees.

      HOLOGIC, INC.

      Hologic, Inc. is a private company founded in 1985 and based in the United States with 7,070 employees.

      AGFA-GEVAERT GROUP

      Agfa-Gevaert Group is a public company founded in 1867 and based in Belgium with 4,211 employees.

      CURVEBEAM AI, LTD.

      CurveBeam AI, Ltd. is a public company founded in 2009 and based in the United States with 50 employees.

      Reasons to Buy this Report

      • Market Size & Growth Validation : Obtain precise market valuation data for Japan (USD 2,155.4M in 2025) with verified 7.2% CAGR projections through 2030, enabling accurate financial forecasting and investment decision-making specific to the Japanese market.
      • Competitive Landscape Intelligence : Understand Japan's unique competitive dynamics, including local manufacturer dominance, regional healthcare provider preferences, and technology adoption patterns that differ significantly from global markets.
      • Demographic-Driven Opportunity Analysis : Leverage detailed insights into Japan's aging population impact on imaging demand, enabling targeted product development and market entry strategies aligned with the country's specific healthcare needs and patient demographics.
      • Regulatory & Reimbursement Framework : Access Japan-specific information on government healthcare policies, insurance reimbursement structures, and regulatory requirements essential for market entry, pricing strategy, and compliance planning.
      • Technology Adoption Trends : Identify Japan's preference for advanced imaging modalities, AI integration, and hybrid systems, providing actionable intelligence for product positioning and innovation roadmap development in this high-tech healthcare market.

      Frequently asked questions

      What is the current size of Japan's diagnostic imaging market?

      Japan's diagnostic imaging market is valued at USD 2,155.4 million in 2025 and is projected to reach USD 3,045.6 million by 2030.

      What is the growth rate of Japan's diagnostic imaging market?

      Japan's diagnostic imaging market is growing at a compound annual growth rate (CAGR) of 7.2% from 2025 to 2030.

      What factors are driving growth in Japan's diagnostic imaging market?

      Key drivers include Japan's aging population, rising chronic disease prevalence, government healthcare investments, and adoption of AI-integrated imaging technologies.

      Which imaging modalities are most in demand in Japan?

      MRI, CT scanners, and ultrasound systems are among the most demanded diagnostic imaging modalities in Japan due to their diagnostic accuracy and clinical applications.

      How does Japan's market growth compare to global trends?

      Japan's 7.2% CAGR significantly exceeds the global diagnostic imaging market CAGR of 4.4%, reflecting stronger regional demand and healthcare investment.

      RESEARCH METHODOLOGY

      The study involved four major activities in estimating the current size of the diagnostic imaging market. Exhaustive secondary research was done to collect information on the peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

      Secondary Research

      The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial diagnostic imaging market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

      Primary Research

      In the primary research process, various supply and demand sources were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the diagnostic imaging market. The primary sources from the demand side include medical OEMs, CDMOs, and service providers. Primary research was conducted to validate the market segmentation, identify key players, and gather insights on key industry trends & key market dynamics.

      A breakdown of the primary respondents is provided below:

      Diagnostic Imaging Market

      Note 1: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

      Note 2: D-level executives include directors of operations, directors of finance, directors of marketing, and directors of product management

      Note 3: C-level executives include chief executive officers, chief financial officers, chief operating officers, and chief marketing officers.

      Note 4: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 2 billion, Tier 2 = USD 50 million to USD 2 billion, and Tier 3 = < USD 50 million.

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      In this report, the size of the diagnostic imaging market was determined using the revenue share analysis of leading players. For this purpose, key players in the market were identified, and their revenues from the market business were determined through various insights gathered during the primary and secondary research phases. Secondary research included studying the annual and financial reports of the top market players. In contrast, primary research included extensive interviews with key opinion leaders, such as CEOs, directors, and key marketing executives.

      Segmental revenues were calculated based on the revenue mapping of major product providers to calculate the global market value. This process involves the following steps:

      • Generating a list of major global players operating in the diagnostic imaging market
      • Mapping annual revenues generated by major global players from the product segment (or nearest reported business unit/category)
      • Mapping the revenues of major players to cover a major share of the global market, as of 2024
      • Extrapolating the global value of the diagnostic imaging market industry
      Diagnostic Imaging Market

      Data Triangulation

      After arriving at the overall market size from the market size estimation process explained above, the global diagnostic imaging market was split into segments and subsegments. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides. Additionally, the diagnostic imaging market was validated using top-down and bottom-up approaches.

      Market Definition

      Diagnostic imaging involves the use of various diagnostic modalities to visualize a patient’s anatomy. This market addresses the industry focusing on various technologies used for the detection, monitoring, and diagnosis of different medical conditions. Different imaging modalities include computed tomography (CT), ultrasound, X-ray imaging, MRI, nuclear imaging, and mammography technologies. These modalities help healthcare professionals to visualize the internal structure and other surrounding tissues. Diagnostic imaging equipment is primarily used in hospitals, diagnostic imaging centers, and ambulatory imaging centers.

      Stakeholders

      • Senior Management
      • End Users
      • R&D Department
      • Finance/Procurement Department

      Report Objectives

      • To define, describe, and forecast the size of the diagnostic imaging market based on modality, application, end user, and region
      • To provide detailed information regarding the major factors influencing the growth potential of the global diagnostic imaging market (drivers, restraints, opportunities, challenges, and trends)
      • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the global diagnostic imaging market
      • To analyze key growth opportunities in the global diagnostic imaging market for key stakeholders and provide details of the competitive landscape for market leaders
      • To forecast the size of market segments and/or subsegments with respect to five major regions: North America (US and Canada), Europe (Germany, France, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (Japan, China, India, Australia, South Korea, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America), and the Middle East & Africa
      • To profile the key players in the diagnostic imaging market and comprehensively analyze their market shares and core competencies
      • To track and analyze the competitive developments undertaken in the global diagnostic imaging market, such as product launches, agreements, expansions, alliances, and mergers & acquisitions

       

      Get the Full Diagnostic Imaging Market Report

      Full forecast, segment splits, and company analysis for all Diagnostic Imaging Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status